Venture Capital

Nitride Raises Funding From Accelerate Venture Partners and eGrowth Ventures

By Amit Chowdhry ● Feb 10, 2026

Nitride Global announced it has closed an investment from Wichita-based venture capital firms Accelerate Venture Partners and eGrowth Ventures as part of a convertible note financing round, with the company indicating the closing took place in the fourth quarter of 2025. The company, which describes itself as a global leader in aluminum nitride material technologies, positioned the financing as a step toward expanding capacity and accelerating the commercialization of its advanced materials portfolio.

ILiAD Biotechnologies: $115 Million Series B Closed To Advance Intranasal Pertussis Vaccine

By Amit Chowdhry ● Feb 10, 2026

ILiAD Biotechnologies, an advanced clinical stage biotechnology company focused on preventing and treating disease caused by Bordetella pertussis, announced it has closed an oversubscribed $115 million Series B financing to advance BPZE1, its next-generation pertussis vaccine candidate.

Bretton AI: $75 Million Series B Secured For Financial Crime Compliance Platform

By Amit Chowdhry ● Feb 10, 2026

Bretton AI, formerly Greenlite AI, said it has raised a $75 million Series B funding round and rebranded as Bretton AI as it expands its mission to define how AI is deployed across financial crime operations in regulated financial institutions. The round was led by Sapphire Ventures, with continued participation from existing investors Greylock, Thomson Reuters Ventures, Canvas Ventures, and Y Combinator. New investors include TIAA Ventures. Sapphire Ventures Partner Rajeev Dham has joined Bretton AI’s board. The company said the financing comes less than one year after its Series A.

Pelgo: $5.5 Million Seed Funding Raised For AI-Based Career Transition Platform

By Amit Chowdhry ● Feb 10, 2026

Pelgo, an AI-based career transition agent, said it has raised $5.5 million in seed funding to support product development, expand its AI and engineering teams, and fuel go-to-market efforts ahead of an initial product launch in early February. The round was led by Flybridge Capital Partners, with participation from ENIAC Ventures, Primary Venture Partners, and 645 Ventures.

Trener Robotics Raises $32 Million Series A For Agentic Physical AI Platform

By Amit Chowdhry ● Feb 10, 2026

Trener Robotics, formerly known as T-Robotics, said it has raised a $32 million Series A round to scale Acteris, its agentic AI platform that brings “physical intelligence” to industrial automation by enabling software-defined control of robots. The round was co-led by Engine Ventures and IAG Capital Partners, with participation from strategic investors Cadence and Geodesic Capital through Nikon’s NFocus Fund. Trener said the financing comes on the heels of its seed round and brings total funding to over $38 million.

Solace Health: $130 Million Series C At Over $1 Billion Valuation Raised For Healthcare Advocacy Platform

By Amit Chowdhry ● Feb 10, 2026

Solace Health announced it has raised a $130 million in Series C financing to accelerate its effort to make healthcare advocacy a standard part of care for patients across the United States, positioning advocacy as essential infrastructure as costs rise and care delivery becomes more fragmented. The round was led by IVP and included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. Solace said the financing values the company at over $1 billion.

Stoke Space Technologies Extends Series D Financing To $860 Million For Reusable Rockets

By Amit Chowdhry ● Feb 10, 2026

Stoke Space Technologies, the rocket company developing fully and rapidly reusable medium-lift launch vehicles, said it has extended its previously announced Series D financing, bringing the total raised in the round to $860 million.

4Moving Biotech Closes €12 Million Financing To Push Knee Osteoarthritis Drug Toward Phase 2a Proof Of Concept

By Amit Chowdhry ● Feb 10, 2026

4Moving Biotech (4MB), a clinical-stage biotechnology company spun out of 4P-Pharma, said it has closed a €12 million financing to advance its lead disease-modifying osteoarthritis drug (DMOAD) program for knee osteoarthritis, a condition the company says represents a major unmet medical need.

BotGauge AI Raises $2 Million Seed Funding For Autonomous QA Platform

By Amit Chowdhry ● Feb 10, 2026

BotGauge AI, a U.S.-headquartered autonomous quality-assurance-as-a-solution startup, has raised $2 million in funding led by Surface Ventures, with participation from IA Seed Ventures and Saka Ventures.

ArrayPatch: First Close Of €3 Million Funding Raised To Advance Microneedle Patch Treatment For Nail Fungus

By Amit Chowdhry ● Feb 10, 2026

ArrayPatch, a Cork, Ireland-based biotech developing microneedle-based therapeutics, has announced the first close of a €3 million seed funding round to advance its lead program, ITZ-DerMap, a therapeutic designed to treat onychomycosis, commonly known as nail fungus.

Deep Fission: $80 Million Secured And Blue Owl Tie-Up For Digital Infrastructure Power Deployments

By Amit Chowdhry ● Feb 10, 2026

Deep Fission said it has raised $80 million in new financing to accelerate the commercialization of its advanced nuclear approach, which places small modular pressurized water reactors in boreholes about one mile underground. The Berkeley-based company said the capital raise was completed through a private placement of 5,333,333 restricted shares of common stock at $15.00 per share.

Garner Health: $118 Million Series D At $1.35 Billion Valuation Raised For Digital Care Navigation Platform

By Amit Chowdhry ● Feb 10, 2026

Garner Health announced it has raised $118 million in Series D funding to scale its provider-ranking and incentive platform, which the company says helps patients find higher-quality doctors while lowering healthcare costs for employers and members. Garner said the round values the company at $1.35 billion and brings total capital raised to approximately $200 million.